FDA Adverse Event Injury Summary report: N

QUADRA-H CEMENTLESS, HA COATED STD STEM SIZE 3, SHORT NECK

MDR report key: 7897542 · Received September 21, 2018

Report

Report Number
3005180920-2018-00716
Event Type
Injury
Date Received
September 21, 2018
Date of Event
August 28, 2018
Report Date
September 21, 2018
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JDI
UDI-DI
07630030802638
PMA / PMN Number
K082792
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 18 SEPTEMBER 2018: LOT 177576: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 12 MARCH 2018. EXPIRATION DATE: 2023-03-04. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. ADDITIONAL PRODUCT IMPLANTED IN PRIMARY, NOT EXPLANTED DURING THE ADDITIONAL SURGERY: CUP: MPACT 01.32.152DH ACETABULAR SHELL Ø52 TWO-HOLES (K132879), LOT 172585: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 03 OCTOBER 2017. EXPIRATION DATE: 2022-09-24. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. CLINICAL EVALUATION PERFORMED BY MEDICAL AFFAIRS MANAGER ON SEP 4, 2018: INTRAOPERATIVE FEMORAL FRACTURES ARE KNOWN POSSIBLE ADVERSE EVENTS OF TOTAL HIP REPLACEMENTS, DESCRIBED AND QUANTIFIED IN LITERATURE. THEY MAINLY DEPEND ON BONE MORPHOLOGY AND MECHANICAL PROPERTIES. IN THIS CASE, THERE IS NO REASON TO SUSPECT A MALFUNCTIONING DEVICE.

Description of Event or Problem · 1

ON (B)(6) 2018 THE AGENT WAS IN THEATRE WITH THE SURGEON WHO INFORMED HIM THAT THE PATIENT WAS FOUND TO HAVE A GT FRACTURE IMMEDIATELY AFTER PRIMARY CASE. THE INTRA-OP X-RAY TAKEN DURING PRIMARY DIDN'T SHOW ANY EVIDENCE OF FRACTURE WITH TRIAL IMPLANTS IN PLACE. HOWEVER THE POST OP XRAY IN RECOVERY SHOWED A POSSIBLE GT FRACTURE. THE PATIENT WAS SENT OFF FOR CT SCAN AND IT WAS CONFIRMED THERE WAS FEMUR, GT AND PELVIC FRACTURE. A MEDACTA REP ATTENDED THE PRIMARY CASE AND SAID THERE WAS NOTHING UNTOWARD DURING THE PROCEDURE, PATIENT WAS NOT OVERWEIGHT AND THERE WAS NO MENTION OF FRACTURE DURING THE PROCEDURE OR UNDERLYING EXTENSIVE DISEASE BONE DISEASE. THE SURGEON STATED THAT THE PATIENT HAD AVN. THE PATIENT WAS REOPERATED ON (B)(6) 2018: NO MEDACTA IMPLANT WAS REVISED, BUT ONLY CABLES WERE APPLIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
738624 QUADRA-H CEMENTLESS, HA COATED STD STEM SIZE 3, SHORT NECK CEMENTLESS HIP STEM JDI MEDACTA INTERNATIONAL SA 01.12.23SN 177576 07630030802638

Patients

Seq Age Sex Outcome Treatment
1 39 YR Required Intervention